|
시장보고서
상품코드
2049682
신경 수복 및 재생 시장 보고서 : 수술별, 제품별, 최종사용자별, 지역별(2026-2034년)Nerve Repair and Regeneration Market Report by Surgery, Product, End User, and Region 2026-2034 |
||||||
세계의 신경 수복 및 재생 시장 규모는 2025년에 103억 달러에 달했습니다. 향후 IMARC Group은 2026년부터 2034년까지 CAGR 9.08%로 성장하여 2034년까지 231억 달러에 달할 것으로 예측하고 있습니다.
신경 수복 및 재생(NRaR)은 신경손상 치료에 사용되는 신경조직공학의 한 과정입니다. 이는 새로운 뉴런, 신경교세포, 미엘린, 축삭, 시냅스의 재생을 촉진합니다. 또한 일반적으로 압박, 무딘 외상, 신장 또는 절단으로 인한 신경 손상 후 신경의 정상적인 기능을 회복하는 데 도움이 됩니다. NRaR에는 생체 재료와 다양한 신경 자극 및 신경 조절 장치의 사용이 포함됩니다. 생체재료에는 신경도관, 신경보호재, 신경붕대, 신경접합재 등이 있습니다. 이들은 직접 신경 이식, 신경 이식, 줄기세포 치료 및 경피적, 경두개 자기, 척수, 심부 뇌, 천골신경, 미주신경 자극 등에 사용됩니다.
신경 수복 및 재생 시장 동향:
알츠하이머병, 파킨슨병, 근위축성측색경화증(ALS), 다발성 경화증, 다발성 경화증, 다계통위축증 등 만성 신경질환의 유병률 증가는 시장 성장을 이끄는 주요 요인 중 하나입니다. 또한, 이러한 질병에 취약한 고령 인구의 증가와 신경 손상 사례의 증가는 시장 성장을 촉진하고 있습니다. 전 세계 병원, 외래 수술 센터(ASC) 및 기타 의료 기관에서 신경 질환의 조기 진단 및 치료를 위한 새로운 NRaR 솔루션이 제공되고 있습니다. 또한, 줄기세포 치료의 다양한 기술 발전과 혁신적인 신경 조절 장치의 개발도 시장 성장을 촉진하는 요인으로 작용하고 있습니다. 내인성 줄기세포는 중추신경계의 손상된 조직을 효과적으로 복구하고 대체하기 위해 신경 신생, 신경 복구 및 외인성 신경줄기세포 이식에 널리 사용되고 있습니다. 그 외 일반인의 의료비 지출 증가, 특히 개발도상국의 의료 인프라의 현저한 개선 등도 시장 성장을 견인할 것으로 예상됩니다.
본 보고서에서 답변하는 주요 질문
- 2025년 세계 신경 수복 및 재생 시장 규모는 어느 정도였는가?
- 2026년부터 2034년까지 세계 신경 수복 및 재생 시장의 예상 성장률은 어느 정도가 될 것인가?
- 세계 신경 수복 및 재생 시장을 이끄는 주요 요인은 무엇인가?
- COVID-19가 세계 신경 수복 및 재생 시장에 어떤 영향을 미쳤는가?
- 수술별 세계 신경 수복 및 재생 시장의 구성은 어떠한가?
- 제품별 세계 신경 수복 및 재생 시장의 구성은 어떠한가?
- 세계 신경 수복 및 재생 시장은 최종사용자별로 어떻게 세분화되는가?
- 세계 신경 수복 및 재생 시장의 주요 지역은 어디인가?
- 세계 신경 수복 및 재생 시장의 주요 플레이어/기업은 어디인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 신경 수복 및 재생 시장
제6장 시장 내역 : 수술별
제7장 시장 내역 : 제품별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSM 26.06.10The global nerve repair and regeneration market size reached USD 10.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 23.1 Billion by 2034, exhibiting a growth rate (CAGR) of 9.08% during 2026-2034.
Nerve repair and regeneration (NRaR) refers to a neural tissue engineering process used for the treatment of a nerve injury. It facilitates the regrowth of new neurons, glial cells, myelin, axons and synapses. It also aids in restoring the normal functioning of the nerve after nerve damage, which is usually caused by pressure, blunt trauma, stretching or cutting of a nerve. NRaR involves the use of biomaterials and various neuro-stimulation and neuromodulation devices. Biomaterials include nerve conduits, nerve protectors, nerve wraps, and nerve connectors. They are used for direct neuropathy, nerve grafting, stem cell therapy and transcutaneous, transcranial magnetic, spinal cord, deep brain, sacral nerve and vagus nerve stimulation.
NERVE REPAIR AND REGENERATION MARKET TRENDS:
The increasing prevalence of chronic neurological disorders, such as Alzheimer's, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis and multiple system atrophy, is among the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and escalating instances of nerve injuries are providing a thrust to the growth of the market. Hospitals, ambulatory surgical centers (ASCs) and other healthcare institutes across the globe are providing novel NRaR solutions for timely diagnosis and treatment of neurological disorders. Additionally, various technological advancements in stem cell therapy and the development of innovative neuromodulation devices, are acting as other growth-inducing factors. Endogenous stem cells are being widely used in neurogenesis, neural repair and exogenous neural stem cell transplantation for effective repair and replacement of damaged tissues in the central nervous system. Other factors, including rising healthcare expenditures of the masses, along with the significant improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
KEY MARKET SEGMENTATION:
Breakup by Surgery:
- Direct Nerve Repair/Neurorrhaphy
- Nerve Grafting
- Stem Cell Therapy
- Neurostimulation and Neuromodulation Surgeries
Breakup by Product:
- Biomaterial
- Neurostimulation and Neuromodulation Devices
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Vagus Nerve Stimulation Devices
- Gastric Electric Stimulation Devices
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global nerve repair and regeneration market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:
- Abbott Laboratories
- Alafair Biosciences Inc.
- AxoGen Inc.
- Baxter International Inc.
- Boston Scientific Corporation
- Collagen Matrix Inc
- Integra Lifesciences Corporation
- Medtronic plc
- Polyganics BV
- Soterix Medical Inc.
- Stryker Corporation
- Synapse Biomedical Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1.What was the size of the global nerve repair and regeneration market in 2025?
- 2.What is the expected growth rate of the global nerve repair and regeneration market during 2026-2034?
- 3.What are the key factors driving the global nerve repair and regeneration market?
- 4.What has been the impact of COVID-19 on the global nerve repair and regeneration market?
- 5.What is the breakup of the global nerve repair and regeneration market based on the surgery?
- 6.What is the breakup of the global nerve repair and regeneration market based on the product?
- 7.What is the breakup of the global nerve repair and regeneration market based on the end user?
- 8.What are the key regions in the global nerve repair and regeneration market?
- 9.Who are the key players/companies in the global nerve repair and regeneration market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Nerve Repair and Regeneration Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Surgery
- 6.1 Direct Nerve Repair/Neurorrhaphy
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Nerve Grafting
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Stem Cell Therapy
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Neurostimulation and Neuromodulation Surgeries
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Product
- 7.1 Biomaterial
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Neurostimulation and Neuromodulation Devices
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Spinal Cord Stimulation Devices
- 7.2.2.2 Deep Brain Stimulation Devices
- 7.2.2.3 Sacral Nerve Stimulation Devices
- 7.2.2.4 Vagus Nerve Stimulation Devices
- 7.2.2.5 Gastric Electric Stimulation Devices
- 7.2.3 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Alafair Biosciences Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 AxoGen Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 Baxter International Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Boston Scientific Corporation
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Collagen Matrix Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Integra Lifesciences Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Medtronic plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Polyganics BV
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Soterix Medical Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Stryker Corporation
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Synapse Biomedical Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.1 Abbott Laboratories
